marketcaparena
Search

    CLNN

    Clene Inc.

    Company overview

    Market capitalization
    $52.16M
    Employees
    76
    Latest publication
    2026-09-29
    About Clene Inc.

    Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. It develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, the company markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene Inc. is headquartered in Salt Lake City, Utah.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue90,000USD15,000USD77,000USD15,000USD27,000USD81,000USD91,000USD87,000USD
    Cost Of Revenue36,000USD355,000USD23,000USD0USD366,000USD20,000USD18,000USD18,000USD
    Gross Profit54,000USD-340,000USD54,000USD15,000USD27,000USD61,000USD73,000USD69,000USD
    Research Development3,471,000USD329,000USD5,503,000USD3,513,000USD3,514,000USD1,481,000USD5,568,000USD4,471,000USD
    Selling General Administrative1,930,000USD1,747,000USD1,812,000USD2,150,000USD2,193,000USD2,656,000USD2,698,000USD3,413,000USD
    General And Administrative Expenses1,930,000USD———————
    Total Operating Expenses5,401,000USD1,721,000USD7,298,000USD5,663,000USD5,891,000USD4,137,000USD8,728,000USD7,884,000USD
    Operating Income-5,347,000USD-2,061,000USD-7,244,000USD-5,648,000USD-5,864,000USD-4,076,000USD-8,655,000USD-7,815,000USD
    Total Other Income Expense Net-8,077,000USD-6,029,999USD-1,982,000USD-3,129,000USD-1,555,000USD3,325,000USD-4,894,000USD-171,000USD
    Interest Income55,000USD47,000USD40,000USD40,000USD62,000USD81,000USD110,000USD127,000USD
    Interest Expense695,000USD791,000USD746,000USD649,000USD679,000USD608,000USD516,000USD1,022,000USD
    Income Before Tax-13,424,000USD-8,090,999USD-9,226,000USD-8,777,000USD-7,419,000USD-751,000USD-13,549,000USD-7,986,000USD
    Income Tax Expense0USD———————
    Net Income-13,424,000USD-8,090,999USD-9,226,000USD-8,777,000USD-7,419,000USD-751,000USD-13,549,000USD-7,986,000USD
    Net Interest Income—-1,077,000USD-919,000USD-879,000USD-837,000USD-837,000USD-602,000USD-1,087,000USD
    Tax Provision—0USD0USD0USD0USD0USD0USD0USD
    Net Income From Continuing Ops—-8,091,000USD-9,226,000USD-8,777,000USD-7,419,000USD-751,000USD-13,549,000USD-7,986,000USD
    Ebit—-2,061,000USD-8,480,000USD-8,128,000USD-6,740,000USD-143,000USD-13,033,000USD-6,964,000USD
    Ebitda—-1,706,000USD-8,120,000USD-7,763,000USD-6,374,000USD261,000USD-12,628,000USD-6,558,000USD
    Depreciation And Amortization—355,000USD360,000USD365,000USD366,000USD404,000USD405,000USD406,000USD
    Reconciled Depreciation—355,000USD360,000USD365,000USD366,000USD404,000USD405,000USD406,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue200,000USD342,000USD654,000USD473,000USD723,000USD206,000USD0USD—
    Cost Of Revenue43,000USD70,000USD121,000USD26,000USD289,000USD65,000USD900,000USD—
    Gross Profit157,000USD272,000USD533,000USD447,000USD434,000USD141,000USD-900,000USD—
    Research Development14,011,000USD20,058,000USD26,655,000USD31,920,000USD28,416,000USD15,204,000USD8,763,000USD6,645,000USD
    Selling General Administrative9,229,000USD13,307,000USD14,418,000USD16,163,000USD18,813,000USD3,262,000USD6,769,000USD2,515,000USD
    Total Operating Expenses23,240,000USD33,365,000USD41,073,000USD48,856,000USD50,412,000USD20,355,000USD15,432,000USD323,944USD
    Operating Income-23,083,000USD-33,093,000USD-40,540,000USD-48,409,000USD-49,978,000USD-20,214,000USD-16,332,000USD-323,940USD
    Interest Income223,000USD865,000USD1,389,000USD225,000USD————
    Interest Expense2,682,000USD4,064,000USD4,558,000USD3,296,000USD870,000USD950,000USD88,000USD0USD
    Net Interest Income-3,472,000USD-3,960,000USD-4,556,000USD-4,069,000USD-4,053,000USD-950,000USD-88,000USD—
    Income Before Tax-26,173,000USD-39,400,000USD-49,504,000USD-29,918,000USD-10,168,000USD-18,871,000USD-16,155,000USD19,429USD
    Tax Provision0USD0USD0USD-215,000USD-428,000USD406,000USD0USD—
    Net Income-26,173,000USD-39,400,000USD-49,504,000USD-29,918,000USD-9,740,000USD-19,277,000USD-16,155,000USD-277,311USD
    Net Income From Continuing Ops-26,173,000USD-39,400,000USD-40,385,000USD-29,918,000USD-9,740,000USD-19,277,000USD-16,155,000USD—
    Ebit-23,083,000USD-35,336,000USD-44,946,000USD-26,622,000USD-9,298,000USD-17,921,000USD-16,067,000USD-9,160,000USD
    Ebitda-21,588,000USD-33,691,000USD-43,241,000USD-25,603,000USD-8,343,000USD-16,958,000USD-15,167,000USD-8,488,000USD
    Depreciation And Amortization1,495,000USD1,645,000USD1,705,000USD1,019,000USD955,000USD963,000USD900,000USD672,000USD
    Reconciled Depreciation1,495,000USD1,645,000USD1,587,000USD1,019,000USD955,000USD963,000USD848,000USD—
    Total Other Income Expense Net-3,090,000USD-6,307,000USD-8,964,000USD18,491,000USD39,810,000USD1,343,000USD177,000USD343,373USD
    Income Tax Expense——1,537,105USD-14,639,000USD-428,000USD406,000USD115,000USD-375,260USD
    Non Operating Income Net Other———21,787,000USD40,680,000USD2,293,000USD——
    Net Income Applicable To Common Shares———-29,918,000USD-9,740,000USD-19,277,000USD-16,155,000USD-11,654,000USD
    Unclassified Operating Expenses————3,183,000USD1,889,000USD—-8,836,056USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets23,041,000USD21,665,000USD18,131,000USD22,311,000USD22,125,000USD25,314,000USD27,337,000USD31,569,000USD
    Cash And Equivalents9,671,000USD———————
    Total Current Assets14,914,000USD13,023,000USD8,977,000USD12,673,000USD11,985,000USD14,671,000USD16,157,000USD19,698,000USD
    Other Current Assets211,000USD7,030,000USD3,751,000USD4,137,000USD3,302,000USD3,290,000USD3,543,000USD4,574,000USD
    Total Liabilities47,818,000USD———————
    Total Current Liabilities4,852,000USD6,730,000USD10,776,000USD8,305,999USD7,574,000USD10,764,000USD10,291,000USD23,828,000USD
    Other Current Liabilities2,482,000USD———————
    Total Stockholder Equity-24,777,000USD-18,806,000USD-17,592,000USD-12,357,000USD-8,550,000USD-4,973,000USD-8,857,000USD-4,125,000USD
    Total Equity Including Noncontrolling Interest-24,777,000USD———————
    Net Receivables43,000USD2,998,000USD0USD550,000USD1,319,000USD1,511,000USD391,000USD351,000USD
    Inventory37,000USD54,000USD37,000USD61,000USD79,000USD38,000USD68,000USD128,000USD
    Property Plant Equipment Net8,069,000USD8,584,000USD9,096,000USD9,580,000USD10,082,000USD10,585,000USD11,122,000USD11,813,000USD
    Accounts Payable1,142,000USD1,309,000USD892,000USD1,369,000USD828,000USD1,413,000USD1,240,000USD1,678,000USD
    Short Term Debt815,000USD2,692,000USD4,882,000USD2,043,000USD1,387,000USD4,106,000USD1,285,000USD11,607,000USD
    Common Stock1,000USD12,006,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
    Retained Earnings-329,811,000USD-316,387,000USD-308,296,000USD-299,070,000USD-290,293,000USD-282,874,000USD-282,123,000USD-268,574,000USD
    Accumulated Other Comprehensive Income208,000USD216,000USD172,000USD150,000USD149,000USD86,000USD71,000USD223,000USD
    Total Liab—40,471,000USD35,723,000USD34,668,000USD30,675,000USD30,287,000USD36,194,000USD35,694,000USD
    Other Current Liab—2,729,000USD5,002,000USD4,893,999USD4,919,000USD4,790,000USD5,101,000USD8,483,000USD
    Capital Stock—1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
    Cash—5,939,000USD5,189,000USD7,925,000USD7,285,000USD9,832,000USD12,155,000USD14,645,000USD
    Cash And Short Term Investments—5,939,000USD5,189,000USD7,925,000USD7,285,000USD9,832,000USD12,155,000USD14,645,000USD
    Net Debt—16,109,000USD16,484,000USD13,387,000USD13,561,000USD11,109,000USD8,688,000USD8,236,000USD
    Short Long Term Debt—1,866,000USD4,074,000USD1,260,000USD374,000USD3,121,000USD359,000USD10,875,000USD
    Short Long Term Debt Total—22,048,000USD21,673,000USD21,312,000USD20,846,000USD20,941,000USD20,843,000USD22,881,000USD
    Long Term Debt—16,339,000USD13,541,000USD15,785,000USD15,753,000USD12,913,000USD15,426,000USD6,939,000USD
    Property Plant Equipment Gross—18,300,000USD18,457,000USD18,581,000USD18,728,000USD18,865,000USD18,998,000USD19,285,000USD
    Common Stock Shares Outstanding—11,644,214shares9,858,907shares10,284,674shares9,523,592shares8,824,673shares6,954,133shares6,557,839shares
    Non Current Assets Total—8,642,000USD9,154,000USD9,638,000USD10,140,000USD10,643,000USD11,180,000USD11,871,000USD
    Non Current Liabilities Total—33,741,000USD24,947,000USD26,362,000USD23,101,000USD19,523,000USD25,903,000USD11,866,000USD
    Non Currrent Assets Other—58,000USD58,000USD58,000USD58,000USD58,000USD58,000USD58,000USD
    Net Working Capital—6,293,000USD-1,799,000USD4,367,000USD4,411,000USD3,907,000USD5,866,000USD-4,130,000USD
    Unclassified Current Assets—-2,998,000USD——————
    Unclassified Current Liabilities—-1,866,000USD-4,074,000USD-1,260,000USD—-3,121,000USD—-10,875,000USD
    Unclassified Non Current Liabilities—17,402,000USD11,406,000USD10,577,000USD7,348,000USD6,610,000USD10,477,000USD4,927,000USD
    Unclassified Equity—285,358,000USD290,530,000USD286,561,000USD281,592,000USD277,813,000USD273,193,000USD264,224,000USD
    Current Deferred Revenue————440,000USD455,000USD2,665,000USD2,060,000USD
    Short Term Investments——————0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets18,131,000USD27,337,000USD52,341,000USD44,493,000USD63,063,000USD68,243,000USD14,877,000USD47,160,996USD
    Other Current Assets3,751,000USD3,543,000USD2,477,000USD2,871,000USD2,641,000USD1,354,000USD661,000USD46,693USD
    Total Liab35,723,000USD36,194,000USD38,951,000USD41,256,000USD50,466,000USD67,902,000USD9,990,000USD42,160,995USD
    Total Stockholder Equity-17,592,000USD-8,857,000USD13,390,000USD3,237,000USD12,597,000USD341,000USD4,887,000USD5,000,000USD
    Other Current Liab5,002,000USD5,101,000USD3,720,000USD3,863,000USD3,610,000USD9,583,000USD2,929,000USD1,093,001USD
    Common Stock1,000USD1,000USD13,000USD7,000USD6,000USD6,000USD2,000USD199USD
    Capital Stock1,000USD1,000USD13,000USD7,000USD6,000USD6,000USD2,000USD—
    Retained Earnings-308,296,000USD-282,123,000USD-242,723,000USD-193,219,000USD-163,301,000USD-153,561,000USD-69,571,000USD17,042USD
    Cash5,189,000USD12,155,000USD28,821,000USD18,332,000USD50,288,000USD59,275,000USD8,788,000USD743,783USD
    Cash And Short Term Investments5,189,000USD12,155,000USD35,000,000USD23,315,000USD50,288,000USD59,275,000USD8,788,000USD743,783USD
    Total Current Assets8,977,000USD16,157,000USD38,852,000USD29,195,000USD54,583,000USD62,989,000USD9,477,000USD790,476USD
    Total Current Liabilities10,776,000USD10,291,000USD25,330,000USD13,857,000USD6,026,000USD11,668,000USD4,314,000USD222,240USD
    Net Debt16,484,000USD8,688,000USD3,340,000USD13,492,000USD-26,246,000USD-54,952,000USD-5,909,000USD2,480,217USD
    Short Term Debt4,882,000USD1,285,000USD20,106,000USD6,980,000USD493,000USD384,000USD416,000USD3,138,000USD
    Short Long Term Debt4,074,000USD359,000USD19,503,000USD6,418,000USD————
    Short Long Term Debt Total21,673,000USD20,843,000USD32,161,000USD31,824,000USD24,042,000USD4,323,000USD2,879,000USD3,224,000USD
    Long Term Debt13,541,000USD15,426,000USD7,152,000USD19,253,000USD14,484,000USD1,949,000USD640,000USD—
    Net Receivables0USD391,000USD1,338,000USD2,966,000USD1,613,000USD2,169,000USD604,000USD—
    Inventory37,000USD68,000USD37,000USD43,000USD41,000USD191,000USD28,000USD—
    Accounts Payable892,000USD1,240,000USD1,504,000USD3,014,000USD1,923,000USD1,124,000USD889,000USD1,096,000USD
    Property Plant Equipment Net9,096,000USD11,122,000USD13,431,000USD15,240,000USD8,422,000USD5,254,000USD5,400,000USD4,472,000USD
    Property Plant Equipment Gross18,457,000USD18,998,000USD20,318,000USD15,240,000USD8,422,000USD5,254,000USD5,400,000USD—
    Accumulated Other Comprehensive Income172,000USD71,000USD199,000USD203,000USD233,000USD325,000USD41,000USD27,179USD
    Common Stock Shares Outstanding9,858,907shares6,954,133shares5,246,941shares3,260,233shares3,077,923shares3,500,800shares3,471,500shares3,120,096shares
    Non Current Assets Total9,154,000USD11,180,000USD13,489,000USD15,298,000USD8,480,000USD5,254,000USD5,400,000USD46,370,520USD
    Non Current Liabilities Total24,947,000USD25,903,000USD13,621,000USD27,399,000USD44,440,000USD56,234,000USD5,676,000USD41,938,755USD
    Non Currrent Assets Other58,000USD58,000USD58,000USD58,000USD58,000USD-260,000USD-5,400,000USD-4,472,000USD
    Net Working Capital-1,799,000USD5,866,000USD13,522,000USD15,338,000USD48,557,000USD51,321,000USD5,163,000USD—
    Unclassified Current Liabilities-4,074,000USD—-19,503,001USD-6,418,000USD———-5,104,761USD
    Unclassified Non Current Liabilities11,406,000USD10,477,000USD6,384,000USD3,327,000USD-20,891,000USD-50,305,000USD5,036,000USD41,326,755USD
    Unclassified Equity290,530,000USD273,193,000USD255,888,000USD196,239,000USD175,653,000USD153,565,000USD74,413,000USD4,955,580USD
    Current Deferred Revenue—2,665,000USD1USD——413,000USD80,000USD-4,096,000USD
    Short Term Investments—0USD6,179,000USD4,983,000USD0USD———
    Non Current Liabilities Other——85,000USD2,264,000USD11,856,000USD52,035,000USD——
    Other Liab———2,555,000USD20,891,000USD52,295,000USD—612,000USD
    Other Assets———58,000USD58,000USD———
    Net Tangible Assets———3,237,000USD12,597,000USD341,000USD-67,774,000USD-52,039,000USD
    Deferred Long Term Liab————18,100,000USD260,000USD——
    Unclassified Non Current Assets———————41,898,520USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation708,000USD
    Stock Based Compensation2,352,000USD
    Change To Account Receivables-43,000USD
    Change To Inventory0USD
    Change To Liabilities-1,167,000USD
    Change In Working Capital-1,205,000USD
    Operating Cash Flow-7,116,000USD
    Capital Expenditures-1,000USD
    Investing Cash Flow-1,000USD
    Financing Cash Flow11,563,000USD
    Effect Of Forex Changes On Cash36,000USD
    Change In Cash4,482,000USD
    End Cash Flow9,729,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-8,091,000USD-9,226,000USD-8,777,000USD-7,419,000USD-751,000USD-13,549,000USD-7,986,000USD-6,785,000USD
    Depreciation355,000USD360,000USD365,000USD366,000USD404,000USD405,000USD406,000USD414,000USD
    Stock Based Compensation1,312,000USD3,068,000USD1,703,000USD1,367,000USD1,947,000USD1,801,000USD2,188,000USD1,951,000USD
    Other Non Cash Items7,472,000USD155,140USD4,856,985USD1,362,000USD-3,275,000USD4,841,000USD-138,000USD-1,186,000USD
    Change To Account Receivables0USD49USD-49USD0USD64,000USD-64,000USD-24USD64,000USD
    Change To Inventory-17,000USD24,034USD17,966USD-41,000USD30,000USD60,000USD-91,000USD0USD
    Change In Working Capital-4,264,000USD827,000USD-420,125USD-420,000USD-3,336,000USD1,637,000USD2,507,000USD-750,000USD
    Total Cash From Operating Activities-4,528,000USD-4,815,860USD-3,975,140USD-4,744,000USD-5,011,000USD-4,865,000USD-3,023,000USD-6,356,000USD
    Capital Expenditures0USD-28,031USD-10,969USD0USD0USD-1,000USD-1,000USD-2,000USD
    Free Cash Flow-4,528,000USD-4,843,890USD-3,986,110USD-4,744,000USD-5,011,000USD-4,866,000USD-3,024,000USD-6,358,000USD
    Net Borrowings-90,000USD1,411,000USD-124,000USD-171,000USD0USD-869,000USD-10,000,000USD—
    Total Cash From Financing Activities5,234,000USD2,084,597USD4,627,403USD2,133,000USD2,673,000USD2,528,000USD-4,066,000USD28,000USD
    Issuance Of Capital Stock5,324,000USD2,159,000USD3,266,000USD2,304,000USD2,673,000USD7,207,000USD2,036,000USD0USD
    Change In Cash750,000USD-2,736,000USD640,000USD-2,547,000USD-2,323,000USD-2,490,000USD-7,037,000USD-50,000USD
    Begin Period Cash Flow5,189,000USD7,983,000USD7,285,000USD9,890,000USD12,213,000USD14,703,000USD21,740,000USD21,790,000USD
    End Period Cash Flow5,939,000USD5,247,000USD7,925,000USD7,343,000USD9,890,000USD12,213,000USD14,703,000USD21,740,000USD
    Unclassified Operating Cash Flow-1,312,000USD—-1,703,000USD—————
    Investments—0USD-11,000USD0USD0USD-2,000USD-1,000USD6,248,000USD
    Total Cashflows From Investing Activities—-28,026USD-10,974USD——-2,000USD-1,000USD6,248,000USD
    Other Cashflows From Financing Activities—10,021,527USD1,496,473USD——-3,810,000USD3,898,000USD36,000USD
    Unclassified Financing Cash Flow—-11,506,930USD————1,827,465,000USD-1,825,437,000USD
    Other Cashflows From Investing Activities—————32USD1,072USD—
    Sale Purchase Of Stock——————-1,825,429,000USD1,825,429,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-26,173,000USD-39,400,000USD-49,504,000USD-29,918,000USD-9,740,000USD-19,277,000USD-16,155,000USD-277,311USD
    Depreciation1,495,000USD1,645,000USD1,705,000USD1,019,000USD955,000USD963,000USD848,000USD672,000USD
    Stock Based Compensation6,382,000USD7,953,000USD9,117,000USD8,513,000USD12,384,000USD761,000USD399,000USD269,000USD
    Other Non Cash Items3,103,000USD5,265,000USD8,702,000USD-17,085,000USD-39,226,000USD1,970,000USD554,000USD-46,601USD
    Change To Account Receivables64,000USD79,000USD46,000USD-140,000USD-28,000USD-21,000USD-21,000USD-21,000USD
    Change To Inventory31,000USD-31,000USD6,000USD-2,000USD150,000USD-163,000USD-28,000USD-28,000USD
    Change In Working Capital-3,353,000USD3,211,000USD-191,000USD-1,540,000USD1,003,000USD-3,346,000USD1,157,000USD118,540USD
    Total Cash From Operating Activities-18,546,000USD-21,326,000USD-30,171,000USD-39,011,000USD-34,624,000USD-18,929,000USD-13,197,000USD-205,372USD
    Capital Expenditures-39,000USD-15,000USD-330,000USD-5,179,000USD-1,332,000USD-387,000USD-294,000USD-752,000USD
    Free Cash Flow-18,585,000USD-21,341,000USD-30,501,000USD-44,190,000USD-35,956,000USD-19,316,000USD-13,491,000USD-957,372USD
    Investments0USD6,316,000USD6,995,000USD-4,985,000USD-1,332,000USD-387,000USD-294,000USD—
    Total Cashflows From Investing Activities-39,000USD6,316,000USD-1,499,000USD-10,164,000USD-1,332,000USD-387,000USD-294,000USD-46,000,000USD
    Net Borrowings1,116,000USD-10,896,000USD269,000USD5,614,000USD19,461,000USD6,583,000USD-2,576,000USD3,877,000USD
    Total Cash From Financing Activities11,518,000USD-1,529,000USD42,163,000USD17,249,000USD27,112,000USD69,534,000USD5,503,000USD46,949,155USD
    Issuance Of Capital Stock10,402,000USD9,243,000USD53,422,000USD11,460,000USD9,250,000USD35,051,000USD8,069,000USD—
    Change In Cash-6,966,000USD-16,666,000USD10,489,000USD-31,956,000USD-8,929,000USD50,487,000USD-7,989,000USD787,783USD
    Begin Period Cash Flow12,213,000USD28,879,000USD18,390,000USD50,346,000USD59,275,000USD8,788,000USD16,777,000USD-44,000USD
    End Period Cash Flow5,247,000USD12,213,000USD28,879,000USD18,390,000USD50,346,000USD59,275,000USD8,788,000USD743,783USD
    Other Cashflows From Financing Activities1,500,000USD124,000USD-200,000USD229,000USD-1,981,000USD63,603,000USD8,679,000USD15,900,000USD
    Unclassified Financing Cash Flow-1,500,000USD—-11,328,000USD—1,829,000USD-31,770,000USD-8,669,000USD27,172,155USD
    Unclassified Investing Cash Flow——-8,164,000USD—1,332,000USD——-45,248,000USD
    Change To Liabilities———538,000USD2,325,000USD60,000USD-76,000USD257,000USD
    Sale Purchase Of Stock———11,770,000USD7,803,000USD31,118,000USD——
    Cash And Cash Equivalents Changes———-31,926,000USD-8,929,000USD50,487,000USD——
    Other Cashflows From Investing Activities———-2,000USD————
    Exchange Rate Changes————-85,000USD269,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductProduct1,000USD0001437749-26-016878
    Q1 2026Quarterly · 2026-03-31ProductRoyalty14,000USD0001437749-26-016878
    Q4 2025Quarterly · 2025-12-31ProductProduct54,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductRoyalty23,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductProduct119,000USD0001437749-26-008502
    FY 2025Yearly · 2025-12-31ProductRoyalty81,000USD0001437749-26-008502
    Q3 2025Quarterly · 2025-09-30ProductProduct0USD0001437749-25-034613
    Q3 2025Quarterly · 2025-09-30ProductRoyalty15,000USD0001437749-25-034613
    Q2 2025Quarterly · 2025-06-30ProductProduct1,000USD0001437749-25-026679
    Q2 2025Quarterly · 2025-06-30ProductRoyalty26,000USD0001437749-25-026679
    Q1 2025Quarterly · 2025-03-31ProductProduct64,000USD0001437749-26-016878
    Q1 2025Quarterly · 2025-03-31ProductRoyalty17,000USD0001437749-26-016878
    Q4 2024Quarterly · 2024-12-31ProductProduct64,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductRoyalty27,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductProduct237,000USD0001437749-26-008502
    FY 2024Yearly · 2024-12-31ProductRoyalty105,000USD0001437749-26-008502
    Q3 2024Quarterly · 2024-09-30ProductProduct65,000USD0001437749-25-034613
    Q3 2024Quarterly · 2024-09-30ProductRoyalty22,000USD0001437749-25-034613
    Q2 2024Quarterly · 2024-06-30ProductProduct64,000USD0001437749-25-026679
    Q2 2024Quarterly · 2024-06-30ProductRoyalty27,000USD0001437749-25-026679
    FY 2023Yearly · 2023-12-31ProductProduct498,000USD0001437749-25-008956
    FY 2023Yearly · 2023-12-31ProductRoyalty156,000USD0001437749-25-008956
    Q3 2023Quarterly · 2023-09-30SegmentDrugs0USD0001437749-23-030487
    Q3 2023Quarterly · 2023-09-30SegmentSupplements108,000USD0001437749-23-030487
    Q2 2023Quarterly · 2023-06-30SegmentDrugs0USD0001437749-23-023409
    Q2 2023Quarterly · 2023-06-30SegmentSupplements269,000USD0001437749-23-023409
    Q1 2023Quarterly · 2023-03-31SegmentDrugs0USD0001437749-23-014242
    Q1 2023Quarterly · 2023-03-31SegmentSupplements107,000USD0001437749-23-014242
    FY 2022Yearly · 2022-12-31ProductProduct329,000USD0001437749-24-007542
    FY 2022Yearly · 2022-12-31ProductRoyalty144,000USD0001437749-24-007542
    Q4 2022Quarterly · 2022-12-31SegmentDrugs0USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentSupplements234,000USDLegacy provider
    FY 2022Yearly · 2022-12-31SegmentDrugs0USD0001437749-23-006264
    FY 2022Yearly · 2022-12-31SegmentSupplements473,000USD0001437749-23-006264
    Q3 2022Quarterly · 2022-09-30SegmentDrugs0USD0001437749-23-030487
    Q3 2022Quarterly · 2022-09-30SegmentSupplements174,000USD0001437749-23-030487
    Q2 2022Quarterly · 2022-06-30SegmentDrugs0USD0001437749-23-023409
    Q2 2022Quarterly · 2022-06-30SegmentSupplements35,000USD0001437749-23-023409
    Q1 2022Quarterly · 2022-03-31SegmentDrugs0USD0001437749-23-014242
    Q1 2022Quarterly · 2022-03-31SegmentSupplements30,000USD0001437749-23-014242
    FY 2021Yearly · 2021-12-31ProductProduct570,000USD0001437749-23-006264
    FY 2021Yearly · 2021-12-31ProductRoyalty153,000USD0001437749-23-006264
    FY 2021Yearly · 2021-12-31SegmentDrugs0USD0001437749-23-006264
    FY 2021Yearly · 2021-12-31SegmentSupplements723,000USD0001437749-23-006264
    FY 2020Yearly · 2020-12-31ProductProduct176,000USD0000950170-22-003410
    FY 2020Yearly · 2020-12-31ProductRoyalty30,000USD0000950170-22-003410

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.